NCT01127295 2026-04-14
PHACS
Institut Claudius Regaud
Phase 4 Completed
Clinical Trials
12 trialsNCT01553903 2026-04-14
OXYTAM
Institut Claudius Regaud
Phase 4 Completed
NCT01612871 2026-04-14
MIRHO
Institut Claudius Regaud
Phase 4 Completed
NCT05161195 2026-04-02
Roll-over Study to Allow Continued Access to Ribociclib
Novartis
Phase 4 Active not recruiting
NCT03948568 2022-09-30
REaCT-RETT
Ottawa Hospital Research Institute
Phase 4 Completed
NCT03220178 2022-01-06
PRECYCLE
Palleos Healthcare GmbH
Phase 4 Terminated
NCT03238703 2018-12-27
Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer
Fred Hutchinson Cancer Center
Phase 4 Withdrawn
NCT02089854 2016-12-02
AETNBC
Peking Union Medical College Hospital
Phase 4 Unknown
NCT00544986 2013-01-30
A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer
AstraZeneca
Phase 4 Completed
NCT00537771 2013-01-25
HEART
AstraZeneca
Phase 4 Completed
NCT00323479 2012-04-06
Arthralgia During Anastrozole Therapy for Breast Cancer
AstraZeneca
Phase 4 Completed
NCT00082277 2011-01-26
SABRE
AstraZeneca
Phase 4 Completed